The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 05, 2021

Filed:

Jan. 12, 2018
Applicant:

Academia Sinicia, Taipei, TW;

Inventors:

Patrick C. H. Hsieh, Taichung, TW;

David Lundy, Taipei, TW;

Christopher Yu-Tai Yen, Taipei, TW;

Assignee:

ACADEMIA SINICA, Taipei, TW;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/44 (2006.01); A61K 9/06 (2006.01); A61K 39/395 (2006.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); A61K 47/60 (2017.01); A61P 9/10 (2006.01); A61P 9/06 (2006.01); A61K 38/30 (2006.01); C07K 14/475 (2006.01); C07K 14/485 (2006.01); C07K 14/49 (2006.01); C07K 14/495 (2006.01); C07K 14/50 (2006.01); C07K 14/505 (2006.01); C07K 14/52 (2006.01); C07K 14/535 (2006.01); A61K 47/36 (2006.01); C07K 14/65 (2006.01);
U.S. Cl.
CPC ...
A61K 9/06 (2013.01); A61K 38/18 (2013.01); A61K 38/185 (2013.01); A61K 38/1816 (2013.01); A61K 38/1825 (2013.01); A61K 38/1833 (2013.01); A61K 38/1841 (2013.01); A61K 38/1858 (2013.01); A61K 38/1866 (2013.01); A61K 38/1883 (2013.01); A61K 38/193 (2013.01); A61K 38/30 (2013.01); A61K 39/3955 (2013.01); A61K 47/60 (2017.08); A61P 9/10 (2018.01); C07K 16/44 (2013.01); A61K 47/36 (2013.01); C07K 14/475 (2013.01); C07K 14/4753 (2013.01); C07K 14/4756 (2013.01); C07K 14/49 (2013.01); C07K 14/495 (2013.01); C07K 14/50 (2013.01); C07K 14/505 (2013.01); C07K 14/535 (2013.01); C07K 14/65 (2013.01);
Abstract

A drug delivery system and methods of using such for delivering a peglyated therapeutic agent to heart. The drug delivery system may comprise an antibody embedded in a hydrogel, comprising one or more biodegradable polymers, up to about 60% of which contain inter-chain or intra-chain covalent crosslinks.


Find Patent Forward Citations

Loading…